RBC Raises AbbVie Price Target to $330 From $280, Keeps Outperform
RBC raised its price target on AbbVie to $330 from $280 and maintained an Outperform rating.
Related stories
World Stocks Rebound as Oil Falls and Strong Data Is Published
Global equities rebounded as oil prices declined and strong economic data was published.
M impact | EQUITY | Nov 02, 2026, 03:47 PM UTC
Carnelian, HDFC AMC and L&T Acquire 2.9% Stake in EAAA India Alternatives
The investors collectively acquired the stake through open-market transactions on EAAA India Alternatives’ first day of trading, November 2.
M impact | EQUITY | Nov 02, 2026, 03:47 PM UTC
Global stocks rise as oil falls and data prove positive
M impact | EQUITY | Nov 02, 2026, 03:47 PM UTC
Global Stocks Rise as Oil Pullback and Solid Data Lift Sentiment
Global stocks were headed higher after oil prices fell sharply, reversing some of the gloom from Friday’s US tech rout. The Nasdaq was up 1.2% and the S&P 500 rose 1% at the open.
M impact | EQUITY | Nov 02, 2026, 03:46 PM UTC
Cencosud Closes Four Easy Stores in Chile
Cencosud closed four stores in its Easy chain: two in regional areas and two in Santiago.
L impact | EQUITY | Nov 02, 2026, 03:42 PM UTC
Greece Agrees to Acquire Up to Six Embraer KC-390 Jets
Greece agreed to acquire up to six KC-390 Millennium jets from Embraer.
M impact | EQUITY | Nov 02, 2026, 03:41 PM UTC